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  BACKGROUND: Atherosclerosis is the commonest cause of vascular disease which can involve 
peripheral and/or cardiac vessels. This study was conducted to evaluate the possible link between 
Ankle-Brachial Index (ABI) and coronary vessel involvement in patients with stable angina. 
  METHODS: This cross-sectional study was conducted in 2008 on 120 individuals who were 
hospitalized in Chamran Heart Center and underwent coronary angiography. A questionnaire 
was completed to obtain demographic information, history of previous heart disease and smok-
ing. Body height and weight, as blood pressure on hand and foot were measured. The patients 
underwent angiography and the extent of coronary involvement (> 75%) was determined. Af-
ter12-14-hour of fasting, blood sugar was obtained to measure total cholesterol, triglyceride, 
low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C). 
The Ankle Brachial Pressure Index (ABI) was calculated as the ratio of the blood pressure in the 
ankles to the blood pressure in the arms. The data were analyzed by SPSS-15 using ANOVA, T-
Student test, Spearman's rank correlation coefficient, and discriminant analysis. 
  RESULTS:  Samples  were  46  women  (38.33%)  and  74  men  (61.67%)  with  a  mean  age  of  
55.50 ± 10.49. Mean and SD of ABI in men and women was 0.72 ± 0.20 and 0.80 ± 0.19 with no 
significant difference (P = 0.012). The correlation between ABI and extent of coronary involve-
ment was 0.47 (P < 0.0001). The group with lower ABI had the highest levels of coronary in-
volvement (triple vessel, P < 0.05). 
  CONCLUSION: ABI had a significant relationship with the degree of coronary involvement and a 
significant predictive value. Therefore ABI seems to be a reliable indicator of high coronary risk. 
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Coronary artery disease (CAD) affects 20% of the 
Iranian population, accounting for the largest num-
ber of deaths in Iran.1 A similar paradigm has been 
demonstrated in other countries too. Forty percent 
of mortalities in the US are CAD-related.2 Athero-
sclerosis  is  the  commonest  cause  of  coronary  dis-
ease;  more  than  90%  of  heart  attacks  are  due  to 
atherosclerosis.3 
  Atherosclerosis can affect all body vessels. Periph-
eral vessel atherosclerosis may exist with or without 
cardiac  vessel  involvement.4  Risk  factors  related  to 
coronary and peripheral vessels are similar, including 
aging, smoking, hypertension, dyslipidemia, and dia-
betes mellitus.5 
  Peripheral and coronary angiography is the stan-
dard method of detecting vessel involvement; how-
ever, this is an invasive procedure with many compli-
cations. In addition to angiography, non-invasive pro-
cedures e.g. ultrasonography and measurement of the 
Ankle-Brachial  Index  (ABI)  can  be  used  to  detect 
peripheral vessel disease.6 
  The relationship between coronary and peripheral 
vessel  involvement  via  ABI  measurement  is  well 
known in the elderly, but is unclear in individuals with 
moderate risk and stable angina without symptomatic 
peripheral vessel disease.7-9 Based on the prevalence 
of peripheral vessel disease in various countries, the 
predictive value of peripheral and cardiac vessel in-
volvement has been expressed differently.9 In various   M. Sadeghi, A. Tavasoli, H. Roohafza, N. Sarrafzadegan 
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studies,  the  relationship  between  involvement  of 
these vessels is different.10 
  The prevalence of peripheral vessel disease is dif-
ferent  in  various  communities,  ranging  from  4.6  to 
29%.11-14 One study reported a sensitivity of 34.3% and 
specificity of 87% for ABI in predicting coronary in-
volvement  based  on  peripheral  vessel  disease.15  An-
other  study  demonstrated  low  ABI  to  be  associated 
with greater involvement of 3 or 4 coronary vessels.16 
Another  study  reported the  prevalence  of  peripheral 
vessel disease in South India to be significantly lower 
than in Western countries.17 Moreover, most patients 
with peripheral vessel disease in India were found to 
have normal coronaries.18 Given the high prevalence of 
CAD, varying prevalence of peripheral and coronary 
vessel diseases in different societies, varying predictive 
value of ABI, inexpensiveness, ease and accessibility of 
ultrasonographic  measurement,  this  study  was  con-
ducted to examine the relationship between peripheral 
and coronary vessel involvement. 
Materials and Methods 
This cross-sectional (descriptive analytical) study was 
conducted at Isfahan Chamran Heart Center in 2008 
on 120 individuals undergoing coronary angiography 
following presentation with typical chest pain (retros-
ternal  pain  worsening  with  exertion/subsiding  with 
rest). Simple sampling method was used. Question-
naires  obtaining  demographic  information  including 
age/sex, as well as history of hypertension, smoking, 
diabetes  mellitus,  dyslipidemia  and  ischemic  heart 
disease  were  completed  for  patients.  Patients  who 
were  smoking  any  number  of  cigarettes  daily  were 
considered as smokers.19 
  A  trained  person  measured  the  patients'  body 
weight/height when they were lightly dressed and had 
no shoes on. Blood pressure in the ankles and the 
arms was measured. Systolic and/or diastolic pressure 
greater than 140 and 90 mmHg respectively, or use of 
antihypertensive  medications  was  considered  as  hy-
pertension.20  A  Madeco  Biderectional  Smatdop  30 
ultrasonography device (made in Japan) and a pneu-
matic cuff was used by a cardiologist to measure the 
brachial artery and ankle pressure waves. Ankle Bra-
chial Pressure Index (ABI) was calculated as the ratio 
of the blood pressure in ankles to the blood pressure 
in the arms. 
  After  12-14  hours  fasting,  blood  samples  were 
obtained.  Measurement  of  total  cholesterol,  triglyc-
eride  and  blood  glucose  was  performed  by  an 
autoanalyzer  using  the  spectrophotometry  method. 
HDL-C was measured after heparin-manganese sedi-
mentation.21 When triglyceride concentration was be-
low 400 mg/dl LDL-C was calculated with the Fried-
wald formula and when it exceeded 400 mg/dl it was 
determined by an ELAN2000 machine.22 
  Normal total cholesterol, triglyceride and LDL-C 
levels were considered below 240 mg/dl, 200 mg/dl 
and 160 mg/dl, respectively. Normal HDL-C for men 
and women was considered > 40 mg/dl and > 50 
mg/dl, respectively. Any deviation from these defini-
tions and/or use of statins was defined as dyslipide-
mia.23 Fasting blood glucose equal to or greater than 
126 mg/dl or 2-hour blood glucose greater than 200 
mg/dl and/or use of glucose lowering drugs was de-
fined as diabetes.24 
  The degree of involvement was defined as follows: 
1.  No involvement: absence of coronary involvement. 
2.  Single-vessel involvement: coronary occlusion equal 
to or more than 75%. 
3.  Two-vessel involvement: coronary occlusion equal 
to or more than 75% in two coronaries or their 
main branch vessels. As left main is equal to double 
vessel disease, it categorized in this group. 
4.  Triple-vessel involvement: coronary occlusion equal 
to or more than 75% in all three coronaries. 
  ABI equal to or less than 9.0 was considered as 
peripheral vessel disease and ABI greater than 9.0 was 
considered as normal.25 
  The data were analyzed by SPSS15 using ANOVA,  
t-test, Spearman's rank correlation coefficient (to de-
termine the correlation of ABI and degree of coronary 
involvement), and discriminated analysis (to assess the 
predictive value of ABI for coronary involvement). 
Results 
This study was conducted on 120 patients consisting 
of 46 women (38.33%) and 74 men (61.67%) with a 
mean age of 55.50 ± 10.49 years. The patients had 
stable angina and had undergone coronary angiogra-
phy  and  Doppler  ultrasonography  of  limb  vessels. 
The frequency of cigarette smoking at the time was 
15% (8 patients); also 51% (61 patients) had family 
history  of  coronary  disease.  Of  all,  27.5%  (33  pa-
tients) were diabetic, 55.8% (67 patients) were hyper-
tensive, and 70% (84 patients) were dyslipidemic. 
  In table 1, distribution of ABI mean and coronary 
artery involvement is shown. 
 





Coronary artery involvement 
0.882 ± 0.135  No involvement  
0.842 ± 0.036  Single-vessel involvement  
0.687 ± 0.051  Two-vessel involvement  
0.663 ± 0.041  Triple-vessel involvement  
*P = 0.001 ANKLE-BRACHIAL INDEX AND CORONARY INVOLVMENT 
8  ARYA Atherosclerosis Journal 2010 (Spring); Volume 6, Issue 1 










34(49.1%)  17(18.9%)  15(15.1%)  16(17%)  Less than 0.9 
9(26.7%)  7(13.3%)  7(13.3%)  15(46.7%)  More than 0.9  
 
  Mean ABI was 0.72 ± 0.20 and 0.80 ± 0.19 in men 
and  women,  respectively,  with  a  total  average  of  
0.74 ± 0.20. T-test was used to compare mean of ABI 
in men and women; no significant difference was ob-
served (P = 0.12). 
  Also frequency distribution of coronary involve-
ment in patients with stable angina was 28 (23.3%) in 
those with negative angiography results, 18 (15%) in 
patients with single vessel involvement, 21 (17.6%) in 
patients with two-vessel involvement, and 53 (44.1%) 
in patients with triple-vessel involvement. 
  Spearman's rank correlation coefficient was used 
to assess the correlation between ABI and degree of 
coronary  involvement.  The  correlation  coefficient 
measured 47.0 and P < 0.0001. 
  ANOVA was used to compare ABI in groups with 
varying degrees of coronary involvement; a significant 
difference was revealed (P = 0.001). Turkey's test was 
used for further evaluation. Mean of ABI was differ-
ent  in  patients  with  and  without  coronary  involve-
ment;  the  group  with triple-vessel  involvement  was 
significantly different from other groups (P < 0.05). 
  As shown in Table 2, the frequency distribution of 
coronary involvement according to ABI is in the low-
er qualitative band (i.e. > 9.0).  
  The group with lower ABI mostly had triple-vessel 
involvement  and  the  above  9.0  group  were  mostly 
without coronary involvement (P < 0.05). To assess 
the  predictive  value  of  ABI,  the  discriminated  test 
with a stepwise model was used to classify patients 
into four groups, namely without coronary involve-
ment, single-vessel involvement, two-vessel involve-
ment, and triple-vessel involvement. 
  In this test, ABI, age, sex, hypertension, hyperlipi-
demia, diabetes, current smoking history, and family 
history  of  coronary  disease  were  entered  into  the 
model  as  independent  variables  and  only  ABI  re-
mained in the model. The difference between groups 
according to ABI as the predictive variable demon-
strated a predictive value of 5.48% for ABI. 
Discussion 
Based on our results, mean ABI score was not signifi-
cantly different in men and women. We also found a 
link between ABI score in groups with various de-
grees of coronary involvement; the group with lower 
ABI  had  the  highest  degree  of  involvement  (three 
vessels) and the group with ABI > 9.0 were mostly 
without involvement. 
  Various studies have highlighted the link between 
low ABI and peripheral vessel involvement. Guo et al 
studied the sensitivity and specificity of ABI in detect-
ing stenosis of peripheral vessels and demonstrated an 
association  between  decreased  ABI  and  degree  of 
peripheral  vessel  involvement;  the  severest  case  of 
stenosis in their study was associated with the lowest 
ABI. They concluded that ABI is an accurate and reli-
able substitute for traditional angiography of periph-
eral vessels.26 
  Sukhija et al studied the relation between ABI and 
severity  of  CAD  in  patients  with  peripheral  vessel 
involvement  and  CAD  and  reached  similar  conclu-
sions, i.e. patients with lowest ABI (< 4.0) had the 
greatest vessel involvement (3 or 4 vessels).12 In addi-
tion to examining peripheral limb vessels, some stud-
ies have assessed the link between ABI and coronar-
ies.  Furthermore,  studies  specifically  conducted  on 
men and women have assessed the value of ABI in 
predicting cardiovascular accidents in the two sexes. 
  Igarashi et al who used cardiac scanning to identify 
patients with suspected CAD demonstrated a signifi-
cant relationship between coronary involvement and 
low ABI; they suggested that using ABI in addition to 
other risk factors helps identify high-risk individuals 
and  patients.27  The  present  study  confirmed similar 
results. 
  A  systematic  study  conducted  by  Doobay  et  al 
investigated the books and articles in which ABI be-
tween 0.80 and 0.90 had been used to identify indi-
viduals  with  and  without  peripheral  vessel  involve-
ment and had followed these patients to register car-
diovascular  accidents  (death,  stroke  and  myocardial 
infarction). Of 22 studies, 9 were included in meta-
analysis. It was finally concluded that low ABI had 
high  specificity  (92.7%)  in predicting  cardiovascular 
disease; whereas its sensitivity in doing so was only 
16.5%.28 
  A  study  conducted  by  Pearson  investigated  the 
relationship between low ABI and peripheral vessel 
disease, cardiovascular disease and other risk factors 
in women; it demonstrated a special relationship be-
tween low ABI and stenosis of coronary vessels, and 
highlighted ABI as an accurate means for swift identi-
fication of atherosclerotic disease.29   M. Sadeghi, A. Tavasoli, H. Roohafza, N. Sarrafzadegan 
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  Imanishi et al studied the value of ABI in predict-
ing CAD in men and concluded that ABI is an inde-
pendent  predictor  of  risk  in  men  with  a  predictive 
value of 8.81% when associated with chest pain, and 
71.7% without it.30 
Conclusion 
In light of earlier studies and results of the present 
study, we conclude that ABI is an inexpensive and 
suitable  means  of  estimating  peripheral  vessel  in-
volvement and identifying individuals at high risk of 
coronary involvement. 
  We propose that a cohort study be conducted to 
examine  the  relationship  between  ABI  and  risk  of 
cardiovascular disease, in order to assess the predic-
tive value of this finding. 
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